题目内容
DuPont estimates that Monsanto has 98% of the US soybean market and 39% of the corn market.
查看答案
搜索结果不匹配？点我反馈
更多问题
Most of the ethical discussions related to genome editing center around human germline editing. This is because changes made in the germline would be passed down to future generations.
Due to the possibility of off-target effects (edits in the wrong place) and mosaicism (when some cells carry the edit but others do not) of genome editing, safety is of primary concern.
Some researchers and bioethicists are concerned that any genome editing, even for therapeutic uses, will start us on a slippery slope to using it for non-therapeutic and enhancement purposes, which many view as controversial.
It is concerned that the use of genome editing for reproductive purposes will be regulated differently in different countries leading to international unfairness.
微信支付 
支付宝支付